FRANCISCO
CASAS MALDONADO
PROFESOR ASOCIADO CIENCIAS SALUD
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (13)
2023
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Patient-reported outcome measures in severe asthma: an expert consensus
Journal of Asthma
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
-
What's New in the 2022 Consensus for Severe Asthma in Adults
Archivos de Bronconeumologia
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Consensus document for severe asthma in adults. 2022 update
Open Respiratory Archives, Vol. 4, Núm. 3
-
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
ERJ Open Research, Vol. 8, Núm. 3
2020
2016
-
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients
Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152
2012
2010
-
Tolerance and safety of Trypsone®: Prospective follow-up in alpha-1 antitrypsin deficient subjects with pulmonary emphysema
Minerva Pneumologica, Vol. 49, Núm. 2, pp. 83-91